Dyne Therapeutics, Inc. (DYN) Quarterly Cash Flow Statement

120+ quarters historyFree accessUpdated daily

Dyne Therapeutics, Inc. (DYN) quarterly cash flow statement — complete operating, investing & financing history

Quarterly statement

DYN Cash Flow Statement

Dyne Therapeutics, Inc. (DYN) cash flow statement — 19-year operating, investing & financing cash flows

Metric	Q3'26	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24	Q4'23	Q3'23	Q2'23	Q1'23	Q4'22	Q3'22	Q2'22	Q1'22	Q4'21

Cash from Operations	-177.49M	-130.29M	-144.92M	-111.83M	-90.78M	-94.7M	-105.89M	-84.33M	-74.63M	-54.87M	-78.54M	-35.01M	-50.6M	-55.64M	-46.91M	-29.19M	-42.8M	-30.91M	-50.74M	-28.07M
Operating CF Margin %	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating CF Growth %	-95.52%	-37.57%	-36.86%	-32.6%	-21.64%	-72.6%	-34.83%	-140.92%	-47.48%	1.39%	-67.43%	-19.92%	-18.22%	-80.02%	7.55%	-4%	-58.82%	33.02%	-175.86%	-40.09%
Net Income	-193.55M	-178.56M	-120.85M	-111.95M	-108.04M	-110.86M	-115.36M	-89.54M	-97.13M	-65.1M	-65.65M	-66.64M	-60.21M	-64.9M	-44.19M	-38.83M	-41.38M	-52.3M	-35.58M	-51.79M
Depreciation & Amortization	641K	560K	550K	521K	523K	503K	502K	450K	438K	399K	386K	567K	431K	431K	412K	401K	397K	460K	425K	341K
Stock-Based Compensation	16.21M	14.98M	13.08M	11.23M	0	10.52M	13.02M	10.48M	8.74M	6.74M	19.91M	5.73M	4.88M	4.75M	4.62M	3.83M	3.83M	3.03M	4.49M	0
Deferred Taxes	0	0	0	0	0	0	0	0	0	0	0	727K	-365K	0	0	0	0	0	0	0
Other Non-Cash Items	152K	-64K	-76K	-313K	10.87M	-512K	-452K	-635K	-866K	-1.14M	-352K	-921K	166K	-119K	171K	246K	-489K	1.54M	1.68M	6.04M
Working Capital Changes	-936K	32.8M	-37.62M	-11.31M	5.87M	5.64M	-3.6M	-5.08M	14.18M	4.24M	-32.83M	25.53M	4.5M	4.2M	-7.92M	5.16M	-5.16M	16.36M	-21.75M	17.34M
Change in Receivables	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Change in Inventory	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Change in Payables	1.72M	18.96M	-4.8M	-9.46M	18.47M	7.84M	-8.6M	-991K	13.41M	7.38M	-28.76M	21.41M	9.46M	-1.37M	-6.53M	4.65M	-1.16M	1.54M	-6.27M	6.03M
Cash from Investing	-1.29M	-4.79M	-2.39M	982K	-37.97M	6.77M	1.46M	-16.01M	-19.4M	11.17M	-179.84M	26.2M	12.82M	17.23M	27.06M	19.24M	51.66M	18.44M	-2.14M	-235K
Capital Expenditures	-2.01M	-1.51M	-221K	-484K	-19.18M	-60K	-981K	-1.07M	-253K	-857K	-191K	-82K	-167K	-250K	-230K	-519K	-886K	-261K	-1.4M	-1.99M
CapEx % of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Acquisitions	0	0	0	0	0	0	0	0	0	0	0	7.47K	-12.99K	0	23K	34K	0	0	0	0
Investments	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Other Investing	0	9K	30K	10K	0	14K	0	0	0	0	0	-30.47K	12.99K	0	-23K	-34K	0	0	0	0
Cash from Financing	418.1M	58.11M	7.06M	430.96M	217.33M	100.77M	141.24M	3.64M	18.01M	379.86M	408.39M	147K	454K	24.91M	28.82M	37.2M	70K	99K	18K	89K
Debt Issued (Net)	11.23M	57.37M	6.21M	49.45M	-549K	98.8M	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Equity Issued (Net)	406.93M	737K	887K	381.52M	217.88M	1.97M	140.65M	3.64M	18.01M	375.58M	397.47M	-1K	454K	24.14M	28.23M	36.86M	70K	99K	18K	89K
Dividends Paid	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Share Repurchases	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Other Financing	-56K	0	-30K	0	0	0	588K	0	0	4.28M	10.92M	148K	0	764K	587K	342K	0	0	0	0
Net Change in Cash	239.32M	-76.97M	-140.25M	320.12M	88.57M	12.85M	36.81M	-96.71M	-76.02M	336.16M	150.01M	-8.65M	-37.33M	-13.5M	8.97M	27.25M	8.92M	-11.98M	-52.86M	-28.22M
Free Cash Flow	-179.5M	-131.8M	-145.14M	-112.32M	-109.96M	-94.76M	-106.87M	-85.41M	-74.88M	-55.73M	-78.73M	-35.09M	-50.77M	-55.89M	-47.14M	-29.71M	-43.69M	-31.17M	-52.14M	-30.06M
FCF Margin %	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
FCF Growth %	-63.24%	-39.08%	-35.81%	-31.5%	-46.85%	-70.05%	-35.75%	-143.42%	-47.5%	0.3%	-67.02%	-18.1%	-16.2%	-79.31%	9.59%	1.15%	-56.98%	33.52%	-183.34%	-44.8%
FCF per Share	-0.99	-0.80	-0.88	-0.87	-0.78	-0.83	-0.97	-0.84	-0.74	-0.60	-0.97	-0.57	-0.83	-0.93	-0.84	-0.57	-0.84	-0.60	-1.01	-0.58
FCF Conversion (FCF/Net Income)	0.92x	0.73x	1.20x	1.00x	0.84x	0.85x	0.92x	0.94x	0.77x	0.84x	1.20x	0.53x	0.84x	0.86x	1.06x	0.75x	1.03x	0.59x	1.43x	0.54x
Interest Paid	1.13M	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Taxes Paid	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0